We are live on ! Find out more
TC

TFS Capital Portfolio holdings

AUM $255M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
-12.48%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.04B
AUM Growth
+$13.6M
Cap. Flow
+$175M
Cap. Flow %
16.88%
Top 10 Hldgs %
6.41%
Holding
1,241
New
361
Increased
285
Reduced
228
Closed
365

Top Buys

Rank Stock Value
1
AEGN
Aegion Corp
AEGN
+$6.95M
2
PTX
Pernix Therapeutics Holdings, Inc.
PTX
+$6.17M
3
MTOR
MERITOR, Inc.
MTOR
+$6.08M
4
CNCE
Concert Pharmaceuticals, Inc.
CNCE
+$5.62M
5
KRA
Kraton Corporation
KRA
+$5.45M

Top Sells

Rank Stock Value
1
NTUS
Natus Medical Inc
NTUS
+$5.73M
2
ENTA icon
Enanta Pharmaceuticals
ENTA
+$5.45M
3
UNTD
UNITED ONLINE INC COM NEW
UNTD
+$5.41M
4
JIVE
Jive Software, Inc.
JIVE
+$5.4M
5
MMSI icon
Merit Medical Systems
MMSI
+$5.27M

Sector Composition

Rank Sector Weight
1 Healthcare 18.01%
2 Industrials 14.63%
3 Technology 13.41%
4 Consumer Discretionary 11.65%
5 Financials 6.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADMS
101
DELISTED
Adamas Pharmaceuticals
ADMS
$2.67M 0.26%
159,291
+61,639
+63% +$1.4M
IXYS
102
DELISTED
IXYS Corp
IXYS
$2.67M 0.26%
238,764
+50,285
+27% +$607K
XENT
103
DELISTED
Intersect ENT, Inc
XENT
$2.66M 0.26%
113,761
+70,393
+162% +$1.94M
VCRA
104
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$2.62M 0.25%
229,666
+69,363
+43% +$812K
PERY
105
DELISTED
Perry Ellis International Inc
PERY
$2.6M 0.25%
+118,275
New +$2.81M
QLYS icon
106
Qualys
QLYS
$4.84B
$2.57M 0.25%
+90,316
New +$3.03M
AVNS icon
107
Avanos Medical
AVNS
$1.17B
$2.54M 0.24%
89,272
+44,425
+99% +$1.55M
PBY
108
DELISTED
PEP BOYS MANNY MOE& JACK
PBY
$2.53M 0.24%
207,722
+77,426
+59% +$913K
OXM icon
109
Oxford Industries
OXM
$577M
$2.53M 0.24%
34,218
+18,800
+122% +$1.56M
CENTA icon
110
Central Garden & Pet Co Class A
CENTA
$2.41B
$2.52M 0.24%
195,813
+163,580
+507% +$1.66M
AEGR
111
DELISTED
Aegerion Pharmaceuticals
AEGR
$2.52M 0.24%
184,947
+153,996
+498% +$2.74M
MMSI icon
112
Merit Medical Systems
MMSI
$4.43B
$2.51M 0.24%
105,055
-223,890
-68% -$5.27M
PRAH
113
DELISTED
PRA Health Sciences, Inc.
PRAH
$2.47M 0.24%
63,689
+12,834
+25% +$514K
RT
114
DELISTED
Ruby Tuesday Georgia
RT
$2.46M 0.24%
396,887
+146,246
+58% +$966K
GTS
115
DELISTED
Triple-S Management Corporation
GTS
$2.46M 0.24%
145,379
+44,039
+43% +$904K
ROCK icon
116
Gibraltar Industries
ROCK
$1.34B
$2.46M 0.24%
+133,800
New +$2.45M
AMKR icon
117
Amkor Technology
AMKR
$16.1B
$2.45M 0.24%
546,509
-410,689
-43% -$2.02M
CYTK icon
118
Cytokinetics
CYTK
$11B
$2.45M 0.24%
366,042
-533,909
-59% -$3.64M
UFI icon
119
UNIFI
UFI
$117M
$2.44M 0.23%
81,681
+40,734
+99% +$1.24M
ANGO icon
120
AngioDynamics
ANGO
$562M
$2.42M 0.23%
183,798
+48,971
+36% +$739K
CTRN icon
121
Citi Trends
CTRN
$524M
$2.39M 0.23%
102,282
+26,924
+36% +$663K
PTEN icon
122
Patterson-UTI
PTEN
$3.87B
$2.39M 0.23%
181,595
+86,403
+91% +$1.37M
SENEA icon
123
Seneca Foods Class A
SENEA
$1.13B
$2.37M 0.23%
89,864
+79,765
+790% +$2.3M
BCO icon
124
Brink's
BCO
$5.02B
$2.36M 0.23%
+87,271
New +$2.51M
IL
125
DELISTED
IntraLinks Holdings Inc.
IL
$2.35M 0.23%
283,658
+241,884
+579% +$2.57M
3 4
5
6 7

Similar funds

KC
KRV Capital New York $255M AUM 18.27% 1-Year Est. Return
IPC
Independent Portfolio Consultants Boca Raton, Florida $241M AUM 21.8% 1-Year Est. Return
ECPI
Energy Capital Partners III Summit, New Jersey $237M AUM
FRM
Fore Research & Management New York $221M AUM 2.93% 1-Year Est. Return
WFG
Windsor Financial Group Minneapolis, Minnesota $214M AUM 6.66% 1-Year Est. Return
IFB
iAB Financial Bank Fort Wayne, Indiana $204M AUM 19.19% 1-Year Est. Return
KL
Kinsight LLC Birmingham, Alabama $176M AUM 17.21% 1-Year Est. Return
RP
Ridgegate Proprietary Sydney, Australia $154M AUM 25.47% 1-Year Est. Return

TFS Capital's Q3 2015 Portfolio in Review

As of Q3 2015, TFS Capital held 1,241 positions worth $1.04B, up 1.3% from $1.02B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.

TFS Capital deployed $175M of net new capital in Q3 2015, opening 361 new positions and adding to 285 existing holdings. Its largest new stake was Aegion Corp: 384,454 shares worth $6.34M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 21% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Merit Medical Systems, an estimated $5.27M trimmed.

  • TFS Capital's largest Q3 2015 buy was Aegion Corp: 384,454 shares worth $6.34M.
  • TFS Capital added most to Pernix Therapeutics Holdings, Inc. in Q3 2015, an estimated $6.17M increase.
  • TFS Capital's biggest Q3 2015 reduction was Merit Medical Systems, cutting an estimated $5.27M.
  • TFS Capital fully exited Natus Medical Inc in Q3 2015, selling an estimated $5.73M.
  • TFS Capital's ten largest holdings make up 6.4% of its $1.04B portfolio in Q3 2015.
  • TFS Capital opened 361 new positions and closed 365 in Q3 2015.
  • TFS Capital's portfolio value rose 1.3% quarter-over-quarter to $1.04B.

Based on TFS Capital's 13F filing for Q3 2015, filed 3 Nov 2015.